Cilostazol Tablets
utilized to relieve symptoms of intermittent claudication, to support blood flow.
Strengths: 50 · 100mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Pletal
- Therapeutic class
Antiplatelet Agent
- Pharmacological class
Phosphodiesterase-3 Inhibitor
- Contraindications
heart failure; bleeding disorders; hypersensitivity
- Precautions and warnings
discontinue if bleeding occurs; caution in patients with arrhythmia
- Minor side effects
headache; diarrhoea
- Moderate side effects
palpitations; dizziness
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Otsuka
- Onset Time
2–4 weeks
- Duration
long-term
- Storage instructions
Store in a cool, dry place away from sunlight.
- Drug interactions
acetylsalicylic acid; clopidogrel; diltiazem
- Age restrictions
Not established for paediatric use.
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Serious side effects
intracranial haemorrhage — requires immediate medical attention; thrombocytopenia — requires immediate medical attention
Patient summary
utilized to relieve symptoms of intermittent claudication, to support blood flow.
Mechanism of action
Cilostazol inhibits phosphodiesterase-3, preventing the degradation of cyclic adenosine monophosphate in platelets and blood vessels, resulting in antiplatelet effects and vasodilation.
Cilostazol Tablets
utilized to relieve symptoms of intermittent claudication, to support blood flow.
Editorial Notes
- Active ingredient(s): Cilostazol
- Listed indication(s): Intermittent Claudication
Usually available as
- 120 tablets - 50 mg1272-50-mg-15177
- 90 tablets - 100 mg1272-100-mg-15182